EU MDR market accessResearch EU MDR registration records, classification, regulations, timelines, fees, and market updates — the stable entrance to every European Union medical device resource.
Search official EU MDR device registration records.
Paste UDI source material in any format and generate preflighted EUDAMED bulk-upload XML
Paste technical-document evidence and get Annex I findings, missing evidence, and priority actions
Search the official European nomenclature by code or plain device description
Connect post-market signals, clinical evidence, risk, CAPA, and lifecycle reports
Explore market trends, registrations, manufacturers, and local representatives.
Browse official EU MDR regulations and guidance documents.
Review current EU MDR application, review, and renewal fees.
Estimate the likely EU MDR pathway, government fees, dossier preparation time, review timeline, and registration steps.
Follow recent EU MDR policy, guidance, and compliance updates.
Describe your device and get a preliminary EU MDR risk class with an explanation and source links.
Check whether product features may trigger separate radio, electrical, metrology, radiation, import, or other European Union requirements.
Describe a device and find comparable products in the EU MDR registration database.
Browse source-linked lifecycle, language, local-role, renewal, and change-control facts.
Compare the statutory notified-body conformity assessment clock under Regulation (EU) 2026/977 with realistic CE marking times by device class.
23 of 25 research dimensions currently covered · 17 official sources · latest verification 2026-09-07
EMA / national competent authorities registration fees in EUR · reviewed 2026-08-25
| Fee line | Amount | Provenance |
|---|---|---|
| EMA consultation - ancillary medicinal substance not previously evaluated | EUR 114,700 | Verified |
| EMA consultation - ancillary medicinal substance previously evaluated | EUR 57,200 | Verified |
| EMA consultation - change to an ancillary medicinal substance | EUR 5,000 | Verified |
| EMA consultation - absorbed or locally dispersed substance-based device | EUR 86,100 | Verified |
Notified Bodies under EU MDR 2017/745 (EU MDR) review clocks and planning ranges · 4-class (I, IIa, IIb, III) classification
| Class / pathway | Review clock | Planning total | Provenance |
|---|---|---|---|
| Class I(Self-declaration (no notified body)) | 0 days | 6-9 months | Verified |
Newest official EU MDR headlines from the daily-refreshed feed — every row links directly to the authority publication.
European UnionOct 03, 25ECEuropean Commission / MDCGUpdated central list for medical device expert panels now published following first evaluation of applications to the new call for expression of interest for ExpamedEuropean UnionSep 12, 25ECEuropean Commission / MDCGUpdate - Manual on borderline and classification under Regulations (EU) 2017/745 and 2017/746 - September 2025European UnionSep 05, 25ECEuropean Commission / MDCGRegistration - EUDAMED Workshops: 8 October 2025, Rome, Italy - 3 December 2025, Brussels, BelgiumEuropean UnionSep 05, 25ECEuropean Commission / MDCGRegistration - EUDAMED Workshops: 8 October 2025, Rome, Italy - 3 December 2025, Brussels, BelgiumEuropean UnionOfficial EU MDR rules and guidance · 12 of 12 documents linked to official sources
Computed from 563,317 official EUDAMED device record records · data as of 2025-03-11
The target market is carried into each tool. Add the product, evidence, or regulatory change you want to assess.
Structure company, product, model, approval, certificate, and evidence facts before starting European Union work.
Connect the EU MDR route, evidence, labels, local role, timing, and dependencies to a wider launch plan.
Compare an existing authorization and evidence set against EU MDR administrative, testing, labeling, and dossier needs.
Map a product or manufacturing change to EU MDR evidence, notification, timing, and implementation questions.
Assess a current EU MDR update against one product and turn it into an owner-ready action workpaper.
Review connected-device architecture, risks, SBOM, testing, lifecycle controls, and market-specific questions for European Union (EU MDR).
Albania
Austria
Belarus
Belgium
Bulgaria
Czech Republic
Denmark
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Kazakhstan
Liechtenstein
Lithuania
Luxembourg
Netherlands
Norway
Poland
Portugal
Romania
Russia
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
United Kingdom